Company Overview - Tongling Jieya Biotechnology Co., Ltd. was established in 1999, specializing in the research, production, and sales of wet wipes, with over 20 years of industry experience [1]. - The company was listed on the Shenzhen Stock Exchange's Growth Enterprise Market on December 3, 2021, and is currently advancing its investment projects steadily [1]. Financial Performance - In Q1 2025, the company reported a revenue of 1.24 billion yuan and a net profit of 10.06 million yuan [1]. - The company anticipates that its overseas sales will account for over 50% of total sales in 2025, driven by core customer business expansion [3]. Project Developments - The U.S. wet wipes factory is currently under construction, with plans to commence production next year [3]. - The company is strategically adjusting its subsidiary, Jiechuang Medical, and is cautiously investing in it based on market conditions and strategic needs [3]. Market and Product Insights - The company does not foresee significant inventory risks due to its sales-driven production model [4]. - The decline in revenue and gross margin for facial mask products in 2024 is attributed to a strategic shift by a major client, L'Oréal, to in-house production [3]. Shareholder Information - The actual controller of the company has no current plans for share reduction, adhering to regulations regarding information disclosure [4]. - The company's stock price fluctuations are influenced by macroeconomic factors, industry policies, and market sentiment, with no undisclosed significant information affecting operations [4].
洁雅股份(301108) - 2025年5月28日 投资者关系活动记录表